Seres Therapeutics grants inducement equity under Nasdaq Rule 5635(c)(4)
Seres Therapeutics said its board Compensation and Talent Committee granted inducement equity on September 4, 2026, under Nasdaq Listing Rule 5635(c)(4).
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.